Is high-intensity focused ultrasound (HIFU) an option for neoadjuvant therapy for borderline resectable pancreatic cancer patients? – a systematic review

References

• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Linecker M, Pfammatter T, Kambakamba P, et al. Ablation strategies for locally advanced pancreatic cancer. Dig Surg. 2016;33(4):351–359.
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Dixon E. AHPBA/SSO/SSAT consensus conference on resectable and borderline resectable pancreatic cancer: rationale and overview of the conference. Ann Surg Oncol. 2009;16(7):1725–1726.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN) guidelines. Accessed January 3, 2021; Available from: http://www.nccn.org/professionals/physician_gls/recently_updated.asp.
   Google Scholar
• Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13(8):1035–1046.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Mallery S, Gazelle GS, et al. EUS radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50(3):392–401.
   PubMed Web of Science ®Google Scholar
• Sofuni A, Moriyasu F, Sano T, et al. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World J Gastroenterol. 2014;20(28):9570–9577.
   PubMed Web of Science ®Google Scholar
• Ning Z, Xie J, Chen Q, et al. HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients. OTT. 2019;12:1021–1029.
   Web of Science ®Google Scholar
• Dorr LN, Hynynen K. The effects of tissue heterogeneities and large blood vessels on the thermal exposure induced by short high-power ultrasound pulses. Int J Hyperthermia. 1992;8(1):45–59.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhu H, Zhou K, et al. Effects of high‑intensity focused ultrasound treatment on peripancreatic arterial and venous blood vessels in pancreatic cancer. Oncol Lett. 2020;19:3839–3850.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, The PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Oxford Levels of Evidence Working Group. The Oxford 2011 levels of evidence; 2011. Available from: http://www.cebm.net/index.aspx?o¼5653.
   Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yang G, Wang D, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs. 2010;21(4):447–452.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhou D. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: report of 30 cases. Ultrason Sonochem. 2015;27:694–702.
   PubMed Web of Science ®Google Scholar
• Khokhlova TD, Hwang JH. HIFU for palliative treatment of pancreatic cancer. J Gastrointest Oncol. 2011;2(3):175–184.
   PubMedGoogle Scholar
• Li PZ, Zhu SH, He W, et al. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2012;11(6):655–660.
   PubMed Web of Science ®Google Scholar
• Marinova M, Huxold HC, Henseler J, et al. Clinical effectiveness and potential survival benefit of US-guided high-intensity focused ultrasound therapy in patients with advanced-stage pancreatic cancer. Ultraschall Med. 2019;40(5):625–637.
   PubMed Web of Science ®Google Scholar
• Marinova M, Rauch M, Mücke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26(11):4047–4056.
   PubMed Web of Science ®Google Scholar
• Strunk HM, Henseler J, Rauch M, et al. Clinical use of high-intensity focused ultrasound (HIFU) for tumor and pain reduction in advanced pancreatic cancer. Rofo. 2016;188(7):662–670.
   PubMedGoogle Scholar
• Sung HY, Jung SE, Cho SH, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas. 2011;40(7):1080–1086.
   PubMed Web of Science ®Google Scholar
• Vidal-Jove J, Perich E, del Castillo MA. Ultrasound guided high intensity focused ultrasound for malignant tumors: the Spanish experience of survival advantage in stage III and IV pancreatic cancer. Ultrason Sonochem. 2015;27:703–706.
   PubMed Web of Science ®Google Scholar
• Wu F. High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer. World J Gastroenterol. 2014;20(44):16480–16488.
   PubMed Web of Science ®Google Scholar
• Marinova M, Wilhelm-Buchstab T, Strunk H. RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden [Advanced pancreatic cancer: high-intensity focused ultrasound (HIFU) and other local ablative therapies]. Rofo. 2019;191(3):216–227.
   PubMedGoogle Scholar
• Horsman MR, Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res. 2016;57(S1):i90–i98.
   PubMed Web of Science ®Google Scholar
• Datta NR, Gomez Ordonez S, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 2015;41(9):742–753.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – a systematic review and meta-analysis. Radiother Oncol. 2011;100(1):22–32.
   PubMed Web of Science ®Google Scholar
• Kirui DK, Koay EJ, Guo X, et al. Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport. Nanomedicine. 2014;10(7):1487–1496.
   PubMed Web of Science ®Google Scholar
• (a) van der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13(8):1173–1184.
   PubMed Web of Science ®Google Scholar
  (b) Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia. 2001;17(1):1–18.
   PubMed Web of Science ®Google Scholar
• van der Horst A, Versteijne E, Besselink MGH, et al. The clinical benefit of hyperthermia in pancreatic cancer: a systematic review. Int J Hyperthermia. 2018;34(7):969–979.
   PubMed Web of Science ®Google Scholar
• Dimitrov D, Stanislavova N, Angelov D. Influence of the Focussed ultrasound surgery at the patency of abdominal vessels in patients with locally advanced pancreatic cancer. Rentgenologiya i Radiologiya. 2019;3(58):212–219.
   Google Scholar
• Strunk HM, Lützow C, Henseler J, et al. Auswirkungen der US-gesteuerten HIFU-Ablation auf die großen Oberbauchgefäße beim lokal infiltrierenden [Mesenteric vessel patency following HIFU therapy in patients with locally invasive pancreatic cancer]. Ultraschall Med. 2018;6(39):650–658.
   Google Scholar
• Chuong MD, Springett GM, Freilich JM, et al. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys. 2013;86(3):516–522.
   PubMed Web of Science ®Google Scholar
• Festa V, Andriulli A, Valvano MR, et al. Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: meta-analytical evaluation of prospective studies. J Pancreas. 2013;14(6):618–625.
   PubMedGoogle Scholar